Literature DB >> 15878008

Correlation between apoptotic endothelial microparticles and serum interleukin-6 and C-reactive protein in healthy men.

Julio A Chirinos1, Juan P Zambrano, Salim S Virani, Joaquin J Jimenez, Wenche Jy, Eugene Ahn, Lawrence L Horstman, Agustin Castellanos, Robert J Myerburg, Yeon S Ahn.   

Abstract

Inflammation has been associated with increased cardiovascular risk, and endothelial cell (EC) apoptosis has been implicated in atherogenesis. The correlation between circulating concentrations of interleukin-6 (IL-6), C-reactive protein (CRP), and endothelial microparticles (EMPs) expressing an apoptotic (EMP31) or activation (EMP62E) phenotype in 20 middle-aged healthy men was investigated. IL-6 was significantly correlated with EMP31 (r = 0.6, p = 0.004), which persisted after adjusting for body mass index and CRP. CRP was significantly correlated with body mass index (r = 0.49, p = 0.02) but not with EMP31 or EMP62E. EC apoptosis is associated with IL-6 levels in men and might be partially responsible for the increased cardiovascular risk associated with subclinical inflammation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15878008     DOI: 10.1016/j.amjcard.2005.01.063

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  Circulating microparticles in patients with coronary heart disease and its correlation with interleukin-6 and C-reactive protein.

Authors:  Ying Cui; Lihui Zheng; Ming Jiang; Ru Jia; Xiao Zhang; Qishan Quan; Guiqin Du; Dongjin Shen; Xiaodan Zhao; Wenying Sun; Hongwei Xu; Lijuan Huang
Journal:  Mol Biol Rep       Date:  2013-11       Impact factor: 2.316

2.  Reproducibility of endothelial microparticles in children and adolescents.

Authors:  Elise F Northrop; Liming C Milbauer; Kyle D Rudser; Claudia K Fox; Anna N Solovey; Alexander M Kaizer; Robert P Hebbel; Aaron S Kelly; Justin R Ryder
Journal:  Biomark Med       Date:  2019-11-15       Impact factor: 2.851

3.  Transfer of human hepatocyte growth factor reduces inflammation and prevents pulmonary arterial remodeling in monocrotaline-induced.

Authors:  Jianying Chen; Hongzhe Zhang; Rujun Zhang; Zhenjun Liu; Junxian Wang; Mengyuan Xiao; Mingchuan Ba; Feng Yao; Jinghu Liu; Shi'an Huang; Jixin Zhong
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

Review 4.  Endothelial microparticles: sophisticated vesicles modulating vascular function.

Authors:  Anne M Curtis; Jay Edelberg; Rebecca Jonas; Wade T Rogers; Jonni S Moore; Wajihuddin Syed; Emile R Mohler
Journal:  Vasc Med       Date:  2013-07-26       Impact factor: 3.239

5.  Factor VIIa induces extracellular vesicles from the endothelium: a potential mechanism for its hemostatic effect.

Authors:  Kaushik Das; Shiva Keshava; Shabbir A Ansari; Vijay Kondreddy; Charles T Esmon; John H Griffin; Usha R Pendurthi; L Vijaya Mohan Rao
Journal:  Blood       Date:  2021-06-17       Impact factor: 25.476

6.  Endothelial microparticles are increased in congenital heart diseases and contribute to endothelial dysfunction.

Authors:  Ze-Bang Lin; Hong-Bo Ci; Yan Li; Tian-Pu Cheng; Dong-Hong Liu; Yan-Sheng Wang; Jun Xu; Hao-Xiang Yuan; Hua-Ming Li; Jing Chen; Li Zhou; Zhi-Ping Wang; Xi Zhang; Zhi-Jun Ou; Jing-Song Ou
Journal:  J Transl Med       Date:  2017-01-04       Impact factor: 5.531

7.  Association between Urinary Phthalate Metabolites and Markers of Endothelial Dysfunction in Adolescents and Young Adults.

Authors:  Po-Ching Chu; Charlene Wu; Ta-Chen Su
Journal:  Toxics       Date:  2021-02-06

8.  The angiopietin-1-Tie2 pathway prevents rather than promotes pulmonary arterial hypertension in transgenic mice.

Authors:  Lakshmi Kugathasan; Julie Basu Ray; Yupu Deng; Effat Rezaei; Daniel J Dumont; Duncan J Stewart
Journal:  J Exp Med       Date:  2009-09-08       Impact factor: 14.307

9.  The Association of Subclinical Hypothyroidism and Pattern of Circulating Endothelial-Derived Microparticles Among Chronic Heart Failure Patients.

Authors:  Alexander E Berezin; Alexander A Kremzer; Yulia V Martovitskaya; Tatyana A Samura; Tatyana A Berezina
Journal:  Res Cardiovasc Med       Date:  2015-09-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.